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Abstract A macrophage cell line (J774), activated with
interferon-Q and endotoxin to express the inducible form of NO
synthase (iNOS), immediately inhibited the cellular respiration
of co-incubated L-929 fibroblasts or non-activated J774 macro-
phages. The inhibition was potent, rapid and reversible when the
NO was removed by adding oxyhaemoglobin or by inhibiting
iNOS. Exogenously added NO also rapidly and reversibly
inhibited cellular respiration over the same range of NO
concentrations. This inhibition was competitive with oxygen
and due to direct inhibition of cytochrome oxidase. Thus, NO
generated by one cell can regulate the respiration of adjacent
cells, supporting the hypothesis that NO may be a physiological
and/or pathological regulator of cellular respiration, via its
inhibition of cytochrome oxidase.
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1. Introduction
Although there are no known physiological and direct reg-
ulators of mitochondrial respiration and its a⁄nity for oxygen
[1], we and others have shown that nitric oxide (NO) rever-
sibly inhibits mitochondrial and cellular respiration by inhib-
iting cytochrome oxidase in competition with oxygen [2^6].
This suggests that NO may act as a physiological or patho-
logical regulator of mitochondrial respiration and its a⁄nity
for oxygen [7]. Furthermore, it is possible that NO, which is a
highly di¡usible molecule in biological systems, may regulate
respiration in cells other than those that generate it. To test
this hypothesis, we have now co-incubated cells generating
NO with target cells, and have measured their rates of cellular
respiration.
2. Materials and methods
Non-activated macrophages (J774 murine macrophage cell line
ATCC TIB 67) were maintained in suspension culture in RPMI
1640 with 25 mM HEPES, 10% foetal calf serum, and 2 mM L-glu-
tamine, 100 units/ml penicillin and 100 Wg/ml streptomycin, as in [8].
Only cells in the log phase of growth and with s 90% viability (as-
sayed by trypan blue exclusion) were used for experiments. Activated
macrophages were prepared by resuspending the cells at 2.5U105
cells/ml in Dulbecco’s Modi¢ed Eagle Medium (DMEM) with inter-
feron-Q (murine 50 units/ml) and endotoxin (W S Typhosa 0901, Dif-
co, 10 Wg/ml). The cells were used after 18 h in stirrer culture, and
nitrite formation was assayed by the Griess reaction, as in [8]. The
concentration of nitrite was between 15 and 50 WM in the activated
cultures, and below detection (6 1 WM) in the non-activated cultures.
Viability of the activated cells was between 45 and 70%. Fibroblasts
(mouse C34/AN connective tissue cell line L-929, ECACC no.
85011425) were cultured in tissue culture £asks in RPMI 1640,
2 mM L-glutamine, 10% foetal calf serum, plus penicillin and strepto-
mycin. Cells in the log phase of growth were trypsinized o¡ the plate,
and resuspended in the same incubation medium as that used for NO
and oxygen measurements. Viability was s 95%.
Cells were incubated in a stirred, gas-tight vessel maintained at
37‡C. The incubation medium contained 118 mM NaC1, 4.8 mM
KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 1 mM CaCl, 25 mM HEPES
and 20 mM glucose, pH 7.4. The vessel contained both an oxygen
electrode (Rank Brothers, Bottisham) and an NO electrode (World
Precision Instruments), thus simultaneously measuring O2 and NO
concentration, as in [3]. The NO electrode was calibrated by adding
aliquots of NO-saturated water (2 mM NO) as in [3]. The respiration
rate of cells was calculated from the rate of oxygen consumption,
assuming that air saturated medium contained 0.2 mM O2 at 37‡C,
as in [3].
In experiments designed to assess whether the site of inhibition of
respiration by NO was cytochrome oxidase, the speci¢c inhibitor of
respiratory complex III, myxothiazol [9] was used to prevent the sup-
ply of electrons to cytochrome oxidase from the rest of the respiratory
chain. Carbonyl cyanide p-tri£uoromethoxyphenylhydrazone (FCCP),
a mitochondrial uncoupler, was used to remove any e¡ect of ATP
turnover on cytochrome oxidase activity. Ascorbate and N,N,N1N1-
tetramethyl-p-phenylene diamine (TMPD) were used to supply elec-
trons speci¢cally to cytochrome oxidase within the cells.
To determine whether the e¡ect of NO on cellular respiration is
mediated by the soluble guanylyl cyclase, the e¡ect of a speci¢c in-
hibitor of this enzyme, 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxaline-1-one
(ODQ), was investigated on the respiration of ¢broblasts.
RPMI, DMEM, penicillin, streptomycin and glutamine were from
Gibco-BRL. Interferon-Q was obtained from Insight Biotechnology,
foetal calf serum from Harlan Sera-lab and endotoxin from Difco
Laboratories. All other reagents were from Sigma.
3. Results and discussion
Macrophages in culture (murine macrophage cell line J774)
were activated with interferon-Q and endotoxin for 18 h, and
incubated in a gas-tight vessel containing both an NO elec-
trode and an oxygen electrode, to monitor simultaneously
concentrations of NO and of oxygen (and thus the rate of
cellular respiration). Activated macrophages (107 cells/ml)
produced a steady-state concentration of up to 1.5 WM NO,
whereas non-activated macrophages (cultured in the absence
of interferon-Q and endotoxin) and ¢broblasts (mouse ¢bro-
blast cell line L-929) produced no detectable NO (Table 1).
Addition of activated macrophages to ¢broblasts or non-acti-
vated macrophages resulted in rapid inhibition of the oxygen
consumption (Figs. 1 and 2 and Table 1). Activated macro-
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phages incubated alone respired at only 27% of the rate of
¢broblasts and 67% of the rate of non-activated macrophages
(Table 1), thus in the coincubations where the activated mac-
rophages constituted 25% of the cells they would contribute
approximately 7% of the joint oxygen consumption with the
¢broblasts and about 17% with the non-activated macro-
phages. Thus, as shown in Table 1, the addition of activated
macrophages to ¢broblasts caused the ¢broblast respiration to
fall by at least 75%.
In order to investigate whether the inhibition of respiration
was due to NO, oxyhaemoglobin, which is known to react
rapidly with NO, was added to the co-incubations. This im-
mediately removed NO and reversed the inhibition of respi-
ration, although the reversal of the respiratory inhibition was
possibly not complete (Fig. 1 and Table 1). Similarly, inhib-
ition of NOS with NG-monomethyl-L-arginine (NMMA)
caused the concentration of NO to fall in parallel with a
reversal of the inhibition of respiration (Fig. 2). Subsequent
addition of L-arginine, the substrate for the generation of NO
which competes with NMMA, increased again the generation
of NO and, in parallel, re-imposed the inhibition of respira-
tion (Fig. 2). The inhibition of respiration after addition of
arginine was stronger, even though the NO concentration was
lower (Fig. 2), because the oxygen concentration was low and
cellular respiration was more sensitive to NO at low oxygen
concentrations (see below). This is consistent with the inhibi-
tion being at cytochrome oxidase in competition with oxygen
[3^5]. Addition of haemoglobin, NMMA or L-arginine at the
above concentrations to L-929 cells or non-activated J774
cells alone had no detectable e¡ect on the respiration rates
(6 5% change), indicating that the e¡ect of these agents was
due to their action on NO concentration rather than direct
e¡ects on respiration.
In order to investigate whether NO alone could inhibit cel-
lular respiration we added aliquots of authentic NO to the
cells. Addition of 1 WM NO to the cells (¢broblasts or non-
activated macrophages) caused immediate inhibition of cellu-
lar respiration (see Fig. 2 for e¡ect on macrophages), consis-
tent with NO rapidly di¡using through the cell membrane and
binding to cytochrome oxidase. As the NO added to the me-
dium broke down (due to reaction with oxygen and metabo-
lism by the cells) the inhibition of respiration was reversed
(Fig. 2). This reversibility is consistent with the known rever-
sible inhibition of cytochrome oxidase by NO [2^6,10,11]. We
also tested the sensitivity of cellular respiration to NO at two
di¡erent oxygen concentrations, by adding 1 WM NO to the
¢broblasts (as in Fig. 2) and determining the NO concentra-
tion at which the cellular respiration rate was inhibited by
half. The concentration of NO required to inhibit cellular
respiration rate by half was 0.26 WM NO (mean of two experi-
ments, range 0.09 WM) at an oxygen concentration of 105 WM
O2, and 0.06 WM NO (range 0.01 WM) in two additional ex-
periments using 30 WM O2. Thus, the NO-induced inhibition
of cellular respiration was competitive with oxygen, consistent
with the known competitive inhibition of cytochrome oxidase
[3^6].
To test whether a longer term exposure of cells to NO
would still be reversible, we maintained the NO concentration
in the vessel at the mean of 0.75 WM (range 0.5^1.0 WM NO)
for 10 min by continually adding aliquots of NO. This treat-
ment resulted in a 90% inhibition of respiration during the
10 min exposure to NO; however, following this time, when
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Table 1
Activated macrophages reversibly inhibit the cellular respiration of co-incubated ¢broblasts
Incubation conditions Respiration rate (nmol O2/min/107 cells) NO concentration (WM)
107 activated macrophages alone 6.5 ( þ 0.9) 1.07 ( þ 0.46)
107 non-activated macrophages alone 9.7 ( þ 1.1) 0
7.5U106 ¢broblasts alone 24.2 ( þ 1.5) 0
+2.5U106 activated macrophages 5.1 ( þ 1.5) 0.47 ( þ 0.11)
+7.5 WM oxyhaemoglobin 19.3 ( þ 1.8) 0
The respiration rate and NO concentration of cells were measured as in Fig. 1. The numbers are means and standard deviations of three
experiments for each condition.
Fig. 1. Nitric oxide generated by activated macrophages causes a re-
versible inhibition of respiration in co-incubated ¢broblasts. Fibro-
blasts (0.75 ml of 107 cells/ml) were incubated in a vessel containing
NO and O2 electrodes in order to measure simultaneously NO con-
centration (upper trace) and respiration rate (lower trace). Activated
macrophages (0.25 ml of 107 viable cells/ml) were then added to the
same vessel, resulting in production of NO and inhibition of respira-
tion. The NO was then removed by adding oxyhaemoglobin (8 WM
haem), resulting in reversal of the inhibition of respiration. The oxy-
gen concentration in the vessel increased when the macrophages
were added because the vessel was temporarily opened and because
macrophage medium contained a higher initial level of oxygen. The
oxygen trace levelled o¡ at the end of the experiment because the
vessel was completely depleted of oxygen. In the conditions used all
the NO production is due to the macrophages, but s 90% of the
oxygen consumption is due to the ¢broblasts. The ¢gures next to
the oxygen trace indicate the rate of oxygen consumption in the ad-
joining part of the trace in nmol O2/min/107 cells. Trace representa-
tive of 3 experiments.
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the NO had broken down, the respiration rate returned to
90% of the original value. Thus, the mean respiration rates
(nmol O2/min/107 cells, standard deviation, n = 3) of ¢bro-
blasts at 60 WM O2 were 15 ( þ 1.5) before addition of NO,
1.5 ( þ 0.3) in the presence of NO and 13.2 ( þ 1.2) when the
NO had broken down, respectively. Thus, the inhibition of
cellular respiration is fully reversible following exposure to
NO for 10 min.
This inhibition of ¢broblast respiration by exogenous NO
(90% inhibition at 0.75 WM NO and 60 WM O2) was compa-
rable to that observed with macrophage-derived NO (74%
inhibition at 0.47 WM NO and 60 WM O2, see Table 1).
This similarity in sensitivity again indicates that the inhibition
of respiration induced by activated macrophages is due en-
tirely to NO.
To investigate directly whether the inhibition of respiration
by NO was at cytochrome oxidase, experiments were carried
out in which oxygen consumption of the cells was entirely
dependent on cytochrome oxidase alone. Addition of myxo-
thiazol (0.4 WM) alone to either L-929 cells or non-activated
J744 cells caused complete inhibition of oxygen consumption.
Since myxothiazol is a speci¢c inhibitor of mitochondrial res-
piration [9] this indicates that cellular oxygen consumption is
due to mitochondrial respiration alone. We then added a mi-
tochondrial uncoupler (1 WM FCCP) to myxothiazol-treated
cells to remove any e¡ect of ATP turnover on cytochrome
oxidase activity. Ascorbate (200 WM) and TMPD (80 WM)
were then added to supply electrons speci¢cally to cytochrome
oxidase within the cells. Subsequent addition of NO to the L-
929 cells showed that the concentration of NO required to
inhibit oxygen consumption rates by half in these conditions
was 0.22 WM ( þ 0.04; n = 3) at 80 WM O2. Prior to addition of
these substrates and inhibitors, when the cells were respiring
on glucose, respiration was inhibited by half at 0.18 WM NO
( þ 0.03, n = 3) at 80 WM O2. Since in the presence of myxo-
thiazol, FCCP, TMPD and ascorbate the oxygen consump-
tion is controlled by cytochrome oxidase activity alone and
since in both cases the inhibition occurred at approximately
the same concentrations of NO, these results suggest that the
inhibition of oxygen consumption by NO in both cases is due
solely to the direct inhibition of cytochrome oxidase.
To test whether the e¡ect of NO on respiration is mediated
by stimulation of guanylyl cyclase, we also measured the sen-
sitivity of cellular respiration to NO in the presence of ODQ,
a speci¢c inhibitor of the soluble guanylyl cyclase [12,13].
Incubation of L-929 cells with 20 WM ODQ for 5 min caused
no change in respiration rate and no change in the sensitivity
of respiration to NO. Inhibition of respiration by half oc-
curred at 0.17 WM NO ( þ 0.02, n = 3) in the presence of
ODQ, thus demonstrating that the soluble guanylyl cyclase
is not involved in the inhibition of respiration by NO.
The inhibition of respiration reported here is due to low
concentrations of NO itself, is reversible, is competitive with
O2 and occurs at cytochrome oxidase, either within the cells
generating it or within nearby cells. In contrast, activated
macrophages have previously been shown to inhibit irreversi-
bly the respiration of co-incubated cells after long-term (about
one day) incubation, and this inhibition has been attributed to
irreversible inhibition of aconitase and respiratory complexes
I and II [11,14,15]. This irreversible inhibition might be medi-
ated by peroxynitrite, which is known to inhibit aconitase,
respiratory complexes I and II, and other mitochondrial com-
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Fig. 2. The respiration of non-activated macrophages is reversibly inhibited by exogenous NO or co-incubated activated macrophages, and this
inhibition is reversed by inhibition of iNOS. Non-activated macrophages (0.75 ml of 107 cells/ml) were incubated as in Fig. 1, and an aliquot
of 1 WM NO was added, causing inhibition of respiration which was reversed as the NO broke down. Activated macrophages (0.25 ml of 107
cells/ml) were then added, resulting in production of NO and inhibition of respiration. This inhibition was reversed by adding 0.25 mM NG-
monomethyl-L-arginine (NMMA), an inhibitor of NOS. Inhibition of respiration was restored by adding 5 mM L-arginine (the substrate for
NOS which reverses the action of the competitive inhibitor NMMA) and this respiratory inhibition was again reversed by adding oxyhaemoglo-
bin to remove NO. Trace representative of 3 experiments.
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ponents [10,11], or be mediated by nitrogen dioxide, or may
be due to NO itself which may inhibit complex I after long-
term incubation [16]. The macrophage-induced inhibition of
cellular respiration was possibly not completely reversed by
oxyhaemoglobin (Fig. 1 and Table 1), and any such irrever-
sible inhibition might be mediated by any of the above mech-
anisms.
Many cell types, in response to in£ammation, cytokines,
endotoxins, hypoxia and/or oxidative stress express iNOS,
and this has been shown to cause an initial reversible inhibi-
tion of respiration in astrocytes [17] followed by an irrever-
sible inhibition [18], and an irreversible inhibition in a variety
of other cell types [19^23]. Inhibition of respiration by NO
may contribute to the cytostatic and cytotoxic e¡ects of acti-
vated macrophages and iNOS-expressing cells generally,
which have been implicated both in host defence and in a
variety of pathologies such as sepsis, arthritis, ulcerative col-
itis, Type I diabetes and neurodegenerative disease [24].
Recently it has been shown that mitochondria may contain
a mitochondrial NO synthase (mtNOS), and this NOS may be
involved in regulating mitochondrial respiration [25,26]. We
found that addition of oxyhaemoglobin or NMMA to L-929
or non-activated J774 cells caused no signi¢cant change in
respiration rate (see above), and thus if mtNOS was present
in these cells, it was not signi¢cantly regulating cellular respi-
ration in the conditions used.
Since virtually all cellular processes depend on respiration
and ATP production, it is important to distinguish between
the acute, reversible inhibition of respiration, which may be a
physiological process, and irreversible inhibition, which may
be a pathophysiological mechanism. Current evidence indi-
cates that NO can act as a modulator of mitochondrial res-
piration in physiological conditions and as a disrupter of mi-
tochondrial activity in pathological conditions. The
mechanism(s) by which NO exerts the latter actions remains
to be fully elucidated.
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